Other News To Note
Monday, January 10, 2011
Targeted Genetics Corp., of Seattle, completed acquisition of Biocontrol Ltd., of London. Targeted Genetics will issue 22,586,073 shares of common stock to Biocontrol shareholders, who will then hold about 50 percent of Targeted Genetics. As a condition prior to the acquisition, Biocontrol raised $310,000 in working capital for use by Targeted Genetics.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.